Hong Kong stocks revisit 13-month low as China’s top banks slide on Moody’s act, while reports seen reinforcing slowdown risks

Hong Kong stocks slipped, revisiting a 13-month low, before an official report that may show China’s exports growth stalled last month. Chinese banks dropped after Moody’s lowered the outlook on major players, in lockstep with its recent cut on the nation’s rating outlook.

The Hang Seng Index retreated 1.6 per cent to 16,200.71 at 10am local time, heading for the lowest close since November last year. The Tech Index dropped 1.8 per cent and the Shanghai Composite Index declined 0.5 per cent.

China’s top lender ICBC weakened 0.8 per cent to HK$3.61 while Construction Bank lost 0.7 per cent to HK$4.41. Moody’s lowered their rating outlook to negative from stable to reflect the risk of China’s economic growth. China Merchants Bank tumbled 3.8 per cent to HK$25.55.

Elsewhere, WuXi Biologics failed to sustain a rebound, losing 5.7 per cent to HK$29. Alibaba Group slid 1.7 per cent to HK$68.90 and Tencent lost 2 per cent to HK$305.40.

Bank stocks have suffered a beating in recent months amid concerns Beijing is heaping pressure on them to help ease a liquidity crisis faced by the nation’s property developers, putting their asset quality at risk. Goldman Sachs downgraded ICBC, Agricultural Bank of China and Industrial Bank in July on dividend pressure.

In Hong Kong, four firms get US$2.6 billion support to stem stocks rout

Meanwhile, China will release its external trade data for November today. Overseas shipments probably showed no growth, after six straight months of contraction, according to economists tracked by Bloomberg. Consumer and producer prices likely fell again last month, other reports over the weekend may show.

The Hang Seng Index has dropped 18 per cent this year, making it the worst performer among the world’s key benchmarks this year, erasing about US$630 billion of market value through this week. The sell-offs have led to a slew of stock buy-back plans from Meituan, WuXi Biologics and Swire Pacific to help stem the rout.

Other major Asian markets all fell. Japan’s Nikkei 225 slipped 1.1 per cent, while South Korea’s Kospi retreated 0.4 per cent and Australia’s S&P/ASX 200 lost 0.2 per cent.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Chronicles Live is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – chronicleslive.com. The content will be deleted within 24 hours.

Leave a Comment